Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?

Affiliations

• ¹ Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: j.belderbos@nki.nl.
• ² Radiation Oncology (Maastro), School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
• ³ Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands.
• ⁴ Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands.
• ⁵ Radiation Oncology, UZ Gasthuisberg, Leuven, Belgium.
• ⁶ Radiation Oncology, Ghent University Hospital, Ghent University, Ghent, Belgium.
• ⁷ Radiation Oncology, Amsterdam UMC-Location AMC, Amsterdam, The Netherlands.
• ⁸ Radiation Oncology, Erasmus MC Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
• ⁹ Pulmonology & Thoracic Oncology, Antwerp University Hospital, Antwerp University, Edegem, Belgium.
• ¹⁰ Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
• ¹¹ Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
• ¹² Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
• ¹³ Department of Imaging and Pathology, KU Leuven, Leuven, Belgium, Leuven Cancer Institute (LKI), Leuven, Belgium.
• ¹⁴ Neurology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
• ¹⁵ Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.